EU recommends AstraZeneca bladder cancer treatment for approval
27th May 2025 08:36
(Sharecast News) - EU regulators have recommended AstraZeneca's Imfinzi for approval in the treatment muscle-invasive bladder cancer (MIBC).
Read moreLondon close: Stocks finish choppy week in the black
16th May 2025 16:32
(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.
Read moreLondon close: Stocks rally on US-China tariff deal
12th May 2025 16:30
(Sharecast News) - London stocks ended higher on Monday as investors welcomed news of a temporary trade agreement between the United States and China that will see a rollback of some tariffs.
Read morePharma stocks slide as Trump threatens price cuts in US
12th May 2025 10:13
(Sharecast News) - Shares in pharmaceutical companies fell on Monday after US President Donald Trump threatened to sign an executive order to slash the price of prescription drugs for Americans.
Read moreSunday newspaper round-up: US-China, Aerospace, Pharma
11th May 2025 14:38
(Sharecast News) - The US president said talks with China that were taking place in Geneva had achieved a "total reset" in the two countries' trade relations. Without elaborating, Donald Trump said that great progress had been made and that they wanted to see an opening up of China to American businesses. The negotiations were scheduled to continue on Sunday. - Guardian
Read moreLondon close: FTSE snaps 16-day win streak ahead of Fed
7th May 2025 15:05
(Sharecast News) - London stocks ended lower on Wednesday, with the top-flight index snapping a 16-day winning streak as investor caution ahead of the US Federal Reserve's policy decision weighed on sentiment.
Read moreGSK, AstraZeneca slide after FDA unveils new vaccine lead
7th May 2025 11:32
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Read moreAstraZeneca receives 'positive high-level results' results from Enhertu trial
7th May 2025 09:23
(Sharecast News) - Drugmaker AstraZeneca revealed on Wednesday that it had received "positive high-level results" from a Phase III trial on its specifically engineered HER2-directed DXd antibody drug conjugate Enhertu.
Read moreAstraZeneca's Calquence gets Europe approval for MCL
6th May 2025 08:02
(Sharecast News) - AstraZeneca announced on Tuesday that it has secured European Commission approval for 'Calquence', or acalabrutinib, in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous stem cell transplant.
Read moreAstraZeneca's Breztri meets all primary endpoints in asthma trials
2nd May 2025 10:00
(Sharecast News) - AstraZeneca announced on Friday that its inhaled triple-combination therapy 'Breztri Aerosphere' met all primary endpoints in two phase three trials, delivering statistically significant and clinically meaningful improvements in lung function for patients with uncontrolled asthma.
Read moreAstraZeneca discontinues prostate cancer treatment trial
29th Apr 2025 07:10
(Sharecast News) - AstraZeneca delivered a strong performance in the first quarter of 2025, it announced on Tuesday, with total revenue rising 10% at constant exchange rates to $13.59bn, supported by double-digit growth in oncology and biopharmaceuticals across all major regions.
Read moreAstraZeneca receives positive Phase III trial results from Enhertu study
22nd Apr 2025 08:05
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that it had received "positive high-level results" from a Phase III trial on its Enhertu candidate, developed in conjunction with Daiichi Sankyo.
Read moreLondon close: Stocks fall as China retaliates to latest US tariffs
9th Apr 2025 15:07
(Sharecast News) - London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled retaliatory tariffs in response to a sweeping 104% import charge on Chinese goods announced by US president Donald Trump overnight.
Read moreAstraZeneca's Enhertu gets further EU approval
4th Apr 2025 07:02
(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-low or HER2-ultralow breast cancer, the companies said on Friday.
Read moreLondon close: Stocks slide in global reaction to Trump tariffs
3rd Apr 2025 15:29
(Sharecast News) - London stocks closed sharply lower on Thursday as global markets reacted negatively to US president Donald Trump's unexpectedly aggressive global tariff policy announced overnight.
Read more